Health Beliefs and Obesity Bias as Determinants of Attitudes Toward the Rising Tides of GLP-1 Medications: Mounjaro and Ozempic
This study revealed slightly negative attitudes toward Mounjaro and Ozempic among healthcare professionals and students in Arab countries. The negative attitudes observed likely reflect concerns about side effects, cost, and accessibility of these medications. The findings highlighted the need for targeted education in Arab countries to address obesity bias and encourage a balanced evaluation of the benefits and risks of GLP-1 drugs for weight management.
Authors
- Mohammed Sallam (ORCID: https://orcid.org/0000-0003-3273-524X)
- Kholoud Al-Mahzoum
- Eman Alnazly (ORCID: https://orcid.org/0000-0002-9327-6756)
- Doaa H. Abdelaziz
- Noha O. Mansour (ORCID: https://orcid.org/0000-0002-4448-994X)
- Malik Sallam (ORCID: https://orcid.org/0000-0002-0165-9670)
- Abdullah Alharbi (ORCID: https://orcid.org/0000-0002-5797-1647)
- Sarah Falah Al-Rawi
- Shahad Alrawi (ORCID: https://orcid.org/0009-0007-5296-7749)
- Fajer Alenezi
- Mohammad Khaled Alsubaiei
- Ahmad Hameed Alhajri
- Saif Nasser Alajmi
- Jouza Almutairi
- Fatemah Faisal Bousheheri
Institutions
- Al-Ahliyya Amman University (JO)
- University of Jordan (JO)
- Mansoura University (EG)
- Lund University (SE)
- Jordan Hospital (JO)
- Mediclinic City Hospital (AE)
- Ministry of Health (KW)
- Al-Sabah Hospital (KW)
- National Water Research Center (EG)
- Al Baha University (SA)
Publication Details
- Journal
- Diabetes Metabolic Syndrome and Obesity
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/dmso.s518994
- Citations
- 6
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 12.13